Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Health Place. 2012 Mar 14;18(4):861–868. doi: 10.1016/j.healthplace.2012.03.005

Table 1.

Patient Characteristics for Total Sample and by Cancer Site

Variables Oropharyngeal
(n=555)
Non-Oropharyngeal
(n=579)
Total Sample
(N=1151)

n (%)/M (SD) n (%)/M (SD) N (%)/M (SD)
Neighborhood deprivation**
 Low to Moderate 451 (81.3) 406 (70.1) 863 (75.0%)
 High 104 (18.7) 173 (29.9) 288 (25.0%)
Cancer stage**
 Stage I/II 47 (8.5) 232 (40.1) 283 (24.6%)
 Stage III/IV 508 (91.5) 347 (59.9) 868 (75.4%)
Cancer Treatment**
 Single Modality 188 (33.9) 256 (44.2) 447 (38.8%)
 Multiple Modalities 367 (66.1) 323 (55.8) 704 (61.2%)
Sex**
 Female 82 (14.8) 174 (30.1) 260 (22.6%)
 Male 473 (85.2) 405 (69.9) 891 (77.4%)
Race/Ethnicity**
 Other 65 (11.7) 141 (24.4) 211 (18.3%)
 Non-Hispanic White 490 (88.3) 438 (75.6) 940 (81.7%)
Smoking status**
 Current/Former 342 (61.6) 464 (80.1) 821 (71.3%)
 Never 213 (38.4) 115 (19.9) 330 (28.7%)
Annual household income**
 <$25,000 75 (14.0) 185 (32.6) 265 (23.7%)
 $25,000-74,900 182 (34.0) 250 (44.1) 439 (39.2%)
 ≥$75,000 278 (52.0) 132 (23.3) 415 (37.1%)
Age** 55.7 (9.1) 59.5 (12.0) 57.7 (10.8)
Overall Death Event**
 No 447 (80.5) 415 (71.7) 870 (75.6%)
 Yes 108 (19.5) 164 (28.3) 281 (24.4%)
Disease-specific Death Event*
 No 489 (88.1) 484 (83.6) 984 (85.5%)
 Yes 66 (11.9) 95 (16.4) 167 (14.5%)
Cancer Recurrence Event
 No 463 (83.4) 457 (78.9) 933 (81.1%)
 Yes 92 (16.6) 122 (21.1) 218 (18.9%)
Second Primary Malignancy Event
 No 517 (93.2) 534 (92.2) 1054 (91.6%)
 Yes 38 (6.8) 45 (7.8) 97 (8.4%)
*

Note: p< 0.05

**

p< 0.001: M=mean, SD=standard deviation.